The ‘ collateral benefits ‘ of noninsulin therapies for Type 2 diabetes
نویسندگان
چکیده
145 ISSN 1758-1907 10.2217/DMT.13.5 © 2013 Future Medicine Ltd Diabetes Manage. (2013) 3(2), 145–160 Baylor Endocrine Center, Baylor University Medical Center, 3600 Gaston Avenue, Wadley Tower Suite 656, Dallas, TX 75246, USA University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-9006, USA Baylor Endocrine Center, Baylor University Medical Center, 3600 Gaston Avenue, Wadley Tower Suite 656, Dallas, TX 75246, USA Department of Internal Medicine, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390-8858, USA *Author for correspondence: Tel.: +1 214 648 2017; Fax: +1 214 648 4854; [email protected] Newer noninsulin agents to treat Type 2 diabetes offer more options for treatment intensification.
منابع مشابه
Identifying and addressing barriers to insulin acceptance and adherence in patients with type 2 diabetes mellitus.
Progressive hyperglycemia is a characteristic of type 2 diabetes mellitus (T2DM) that poses a challenge to maintaining optimal glycemic control. Achieving glycemic control early in the course of disease can minimize or prevent serious complications. Most patients with T2DM eventually require insulin replacement therapy to attain and preserve satisfactory glucose control. For decades, the use of...
متن کاملEnhanced glycemic control with combination therapy for type 2 diabetes in primary care
Type 2 diabetes mellitus is an increasingly common medical problem for primary care clinicians to address. Treatment of diabetes has evolved from simple replacement of insulin (directly or through insulin secretagogs) through capture of mechanisms such as insulin sensitizers, alpha-glucosidase inhibitors, and incretins. Only very recently has recognition of the critical role of the gastrointest...
متن کاملPatient Preferences for Noninsulin Diabetes Medications: A Systematic Review
OBJECTIVE An evidence-based synthesis of patient preferences for management of hyperglycemia is needed. Our objective was to systematically review patient preferences for noninsulin diabetes medications in adults with type 2 diabetes. RESEARCH DESIGN AND METHODS We searched the PubMed, Embase, CINAHL, and EconLit databases for articles published on or before 23 January 2013. We included Engli...
متن کاملDiabetes and Oxidative Stress: The Mechanism and Action
Abstract Diabetes mellitus is one of the major metabolic disorders. Diabetes is recognized for severe complications including diabetic nephropathy, neuropathy and retinopathy. Long-lasting effect of hyperglycemia results in increased oxidative stress. Oxidative stress results from an imbalance between radical-generating and radical scavenging systems. Increased oxidative stress has been shown ...
متن کاملResponse to Comment on Schwartz et al. The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell-Centric Classification Schema. Diabetes Care 2016;39:179-186.
We thank Drs. Kalra and and Baruah for their comments (1) on our article (2) in an effort improve the utility of our proposed b-cell–centric classification. We agree that “treatment” is more important than “classification.” We find it frustrating that governments and insurers often think otherwise, limiting therapies of choice on the basis of labels of diabetes mellitus (DM) that are not optima...
متن کامل